行业 发表于 2025-4-1 01:54:11

CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4low-up would be needed to determine the real risk of some rare infections. This chapter evaluates the incidence, risk factors, and proposed prevention for infectious complications related to these drugs.

CHARM 发表于 2025-4-1 06:42:03

http://reply.papertrans.cn/47/4646/464503/464503_62.png
页: 1 2 3 4 5 6 [7]
查看完整版本: Titlebook: Infectious Complications in Biologic and Targeted Therapies; Carlos Cervera,Jose Maria Aguado Book 2022 The Editor(s) (if applicable) and